NEW YORK--(BUSINESS WIRE)--Manhattan Scientifics, Inc. (OTCQB:MHTX) announced today that its Senior Scientific, LLC unit, a nanobiotechnology company for the early detection and localization of cancer and other human diseases, has been granted an additional United States Patent for its MRX™ cancer detection technology. U.S. Patent No. US 9,095,270 B2 entitled "Detection, measurement, and imaging of cells such as cancer and other biologic substances using targeted nanoparticles and magnetic prop